Catalog ID
PTL-SEM
Semaglutide
GLP-1 receptor agonist; weight-management research peptide
Semaglutide, a synthetic GLP-1 receptor agonist modified for extended duration, investigated in appetite signaling, energy-intake regulation and weight-management research models.
Molecular Formula
C187H291N45O59
Formula as supplied.
Purity
≥98%
Molecular Weight
4113.58 g/mol (reported)
Classification
GLP-1 receptor agonist / incretin mimetic
Price
$1.00 – $800.00 USD
Indicative range · converted from USD · free shipping from €500
Pricing tiers · mass & purity
1 mg
$260.00
≥98%
5 mg
$800.00
≥98%
10 mg
$1.00
≥98%
Scientific Background
Semaglutide is a synthetic GLP-1 receptor agonist based on the human glucagon-like peptide-1 sequence, modified for extended duration of action. It is studied in weight-management and metabolic research for effects on appetite regulation, energy intake and glucose-dependent insulin secretion in preclinical and clinical models.
Research Focus — Pathways
GLP-1 receptor signaling; cAMP-mediated insulin secretion; appetite/energy-intake regulation.
Research Areas
- GLP-1 receptor agonism
- Appetite signaling
- Energy intake
- Adiposity research
- Glucose-dependent insulin secretion
Molecular Formula
C187H291N45O59
Formula as supplied.
Molecular Weight
4113.58 g/mol (reported)
Amino Acid Sequence
HAibEGTFTSDVSSYLEGQAAKEFIAWLVRGRG (modified GLP-1 analogue)
Classification
GLP-1 receptor agonist / incretin mimetic
Research Format
Lyophilized research reagent
Purity
≥98%
Peptide Classification
GLP-1 receptor agonist / incretin mimetic
Sequence Notation
HAibEGTFTSDVSSYLEGQAAKEFIAWLVRGRG (modified GLP-1 analogue)
Scientific References
The following authoritative sources provide peer-reviewed literature on Semaglutide. Peptide Hub Biotech World Wide does not claim these sources endorse this product.
Semaglutide — PubChem compound data
PubChem
https://pubchem.ncbi.nlm.nih.gov/#query=SemaglutideGLP-1 precursor — UniProt sequence & function
UniProt
https://www.uniprot.org/search?query=glucagon%20like%20peptide%201Semaglutide — PubMed literature
PubMed / NCBI
https://pubmed.ncbi.nlm.nih.gov/?term=semaglutide
Semaglutide — frequently asked
What is Semaglutide used for in research?
Semaglutide (GLP-1 receptor agonist; weight-management research peptide) is investigated in glp-1 receptor agonism, appetite signaling, energy intake, adiposity research, glucose-dependent insulin secretion research. Semaglutide is a synthetic GLP-1 receptor agonist based on the human glucagon-like peptide-1 sequence, modified for extended duration of action. It is studied in weight-management and metabolic research for effects on appetite regulation, energy intake and glucose-dependent insulin secretion in preclinical and clinical models.
What purity and documentation does Semaglutide include?
Semaglutide is supplied at ≥98% reported purity as a Lyophilized research reagent. A Certificate of Analysis (COA) is available on request with every order.
Does Peptide Hub Biotech World Wide ship Semaglutide to the USA, Canada, Europe, Australia and New Zealand?
Yes. Peptide Hub Biotech World Wide ships Semaglutide to research customers in the United States, Canada, across Europe, Australia, New Zealand and South American markets. Bulk and wholesale quotes are available via the contact form.
How can I order Semaglutide?
Order directly from each product page via our Bitcoin (BTC) checkout — there is no minimum order, and shipping is free on orders from €500 (converted to your local currency). For bulk or wholesale quantities, request a quote through the contact form. After payment, confirm your transaction by email and shipping will proceed.
Related Products
NEWWeight Management≥98%Tirzepatide
Dual GIP/GLP-1 receptor agonist studied in appetite regulation and adiposity research.
NEWWeight Management≥98%Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist studied in adiposity and energy-balance research.
Metabolic & Endocrine99.2%GLP-1 Receptor Agonists
Glucagon-like peptide-1 receptor agonists studied in metabolic and glucose-regulation research.
QC & Quality Systems
Every lot is verified by HPLC and mass-spectrometry purity analysis, peptide-content determination and residual-solvent testing, with a Certificate of Analysis issued per batch — aligned to ISO 9001:2015 and ISO 13485:2016 quality systems, with FDA Drug Master File (DMF) and MDSAP regulatory pathways supported.
ISO 9001:2015
Quality Management System
ISO 13485:2016
Medical Device QMS
FDA DMF
Drug Master File
MDSAP
Medical Device Single Audit Program
Quality & Documentation
Certificate of Analysis available on request · Research Use Only
Request a Quote